We Asked the Experts: Toward Personalized Immunosuppression for Liver Transplant Recipients
- PMID: 35037069
- DOI: 10.1007/s00268-021-06417-5
We Asked the Experts: Toward Personalized Immunosuppression for Liver Transplant Recipients
References
-
- Vionnet J, Miquel R, Abraldes JG et al (2021) Non-invasive alloimmune risk stratification of long-term liver transplant recipients. J Hepatol 75(6):1409–1419 - DOI
-
- Saunders EA, Engel B, Höfer A et al (2021) Outcome and safety of a surveillance biopsy guided personalized immunosuppression program after liver transplantation. Am J Transplant. https://doi.org/10.1111/ajt.16817 - DOI - PubMed
-
- Levitsky J, Kandpal M, Guo K et al (2021) Donor-derived cell-free DNA levels predict graft injury in liver transplant recipients. Am J Transplant. https://doi.org/10.1111/ajt.16835 - DOI - PubMed
-
- Feng S, Bucuvalas JC, Demetris AJ et al (2018) Evidence of chronic allograft injury in liver biopsies from long-term pediatric recipients of liver transplants. Gastroenterology 155:1838–1851 - DOI
-
- Londoño MC, Souza LN, Lozano JJ et al (2018) Molecular profiling of subclinical inflammatory lesions in long-term surviving adult liver transplant recipients. J Hepatol 69:626–634 - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical